Upcoming Dividend • Jun 22
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 29 June 2026. Payment date: 12 August 2026. Trailing yield: 4.8%. Within top quartile of South Korean dividend payers (4.2%). Higher than average of industry peers (1.4%). New Risk • May 28
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 7.5% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 0% Paying a dividend despite having no free cash flows. Earnings have declined by 1.7% per year over the past 5 years. 공고 • Feb 27
Kyung Nong Corporation, Annual General Meeting, Mar 26, 2026 Kyung Nong Corporation, Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 28, hyoryeong-ro 77-gil, seocho-gu, seoul South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩250 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 10 April 2026. Payout ratio is a comfortable 46% but the company is not cash flow positive. Trailing yield: 4.8%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). Reported Earnings • Nov 20
Third quarter 2025 earnings released: ₩174 loss per share (vs ₩84.00 loss in 3Q 2024) Third quarter 2025 results: ₩174 loss per share (further deteriorated from ₩84.00 loss in 3Q 2024). Revenue: ₩45.5b (up 6.2% from 3Q 2024). Net loss: ₩3.11b (loss widened 108% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. New Risk • Aug 21
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 14% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Minor Risk Paying a dividend despite having no free cash flows. Upcoming Dividend • Jun 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 31 July 2025. Payout ratio is a comfortable 52% but the company is not cash flow positive. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.7%). Reported Earnings • Mar 21
Full year 2024 earnings released: EPS: ₩963 (vs ₩1,059 in FY 2023) Full year 2024 results: EPS: ₩963 (down from ₩1,059 in FY 2023). Revenue: ₩325.2b (down 6.4% from FY 2023). Net income: ₩17.2b (down 9.1% from FY 2023). Profit margin: 5.3% (down from 5.4% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 12% per year. 공고 • Feb 22
Kyung Nong Corporation, Annual General Meeting, Mar 25, 2025 Kyung Nong Corporation, Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 28, hyoryeong-ro 77-gil, seocho-gu, seoul South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩250 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 7.1%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). Upcoming Dividend • Sep 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 24 October 2024. Payout ratio is a comfortable 41% and this is well supported by cash flows. Trailing yield: 7.2%. Within top quartile of South Korean dividend payers (3.8%). Higher than average of industry peers (1.9%). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Buy Or Sell Opportunity • Jul 19
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 6.4% to ₩10,410. The fair value is estimated to be ₩8,629, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 13%. Buy Or Sell Opportunity • Jun 14
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 1.6% to ₩10,200. The fair value is estimated to be ₩8,456, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 13%. New Risk • May 25
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 4.9% Last year net profit margin: 7.4% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.9% net profit margin). Reported Earnings • Mar 23
Full year 2023 earnings released: EPS: ₩1,059 (vs ₩1,503 in FY 2022) Full year 2023 results: EPS: ₩1,059 (down from ₩1,503 in FY 2022). Revenue: ₩347.4b (down 3.9% from FY 2022). Net income: ₩18.9b (down 30% from FY 2022). Profit margin: 5.4% (down from 7.4% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩11,470, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 2.9% over the past three years. New Risk • Nov 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0.2% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.3% average weekly change). Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₩12,500, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 13% over the past three years. Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩11,800, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 2.9% over the past three years. Upcoming Dividend • Dec 21
Upcoming dividend of ₩350 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 3.4%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. No independent directors (10 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩11,300, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 36% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. No independent directors (10 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩250 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 07 April 2022. Payout ratio is a comfortable 25% and the cash payout ratio is 79%. Trailing yield: 2.1%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improved over the past week After last week's 15% share price gain to ₩17,300, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 72% over the past three years. Reported Earnings • Mar 28
Full year 2020 earnings released: EPS ₩706 (vs ₩254 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩248.3b (up 9.1% from FY 2019). Net income: ₩12.6b (up 178% from FY 2019). Profit margin: 5.1% (up from 2.0% in FY 2019). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. 공고 • Feb 27
Kyung Nong Corporation, Annual General Meeting, Mar 30, 2021 Kyung Nong Corporation, Annual General Meeting, Mar 30, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Feb 17
New 90-day high: ₩13,600 The company is up 7.0% from its price of ₩12,750 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 29% over the same period. Is New 90 Day High Low • Jan 14
New 90-day high: ₩13,250 The company is up 5.0% from its price of ₩12,600 on 16 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 36% over the same period. Is New 90 Day High Low • Oct 19
New 90-day low: ₩12,450 The company is down 7.0% from its price of ₩13,350 on 21 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period.